Reynolds Cameron John's Form 4 filing
Volitionrx Ltd (VNRX) · filed Oct 15, 2025
- Accession no.
- 0001477932-25-007588
- Filed
- Oct 15, 2025, 4:05 PM ET
- Trade date
- Oct 14, 2025
- Filing delay
- 1 day
- Rule 10b5-1 plan
- Not checked
This filing lists 1 non-derivative transaction and 1 derivative transaction. Open-market purchases total $56.1K. It was filed 1 day after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Reynolds Cameron JohnCIK 0001340610 | Director, Officer (President and CEO) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Oct 14, 2025 | Common Stock | PPurchaseAcquired | +110,000 | $0.51 | +$56,100 | 2,534,847 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Oct 14, 2025 | Common Stock | PPurchaseAcquired | +110,000 | $0.01 | +$1,100 | 110,000 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.